ImmunityBio, Inc. IBRX

Price action is odd seems we should just be on a steady climb with all the great news and active clinical trials.

August 3rd is next estimated earnings date it should show more dramatic sales growth so maybe that will be the catalyst we need and add in papillary cis approval and ?

So sick or posts about shorts or the chart or the or the all stupid

Lance stop posting fake pictures it's really irritating like IAF irritating as fuck

Blackball blackballed

So Dr PSS only has podcasts and social media as options. Why BP MSM back all of ImmunityBio. All about greed and ad $$$$

Question for all posters why is Dr PSS on pod casts? Are they his first choice.

We know papillary and cis will be approved...... we know Anktiva works for lung cancer too. Anktiva work for Gleoblastomas and my be will work for astrocytomas too. It reverses Lymphopenia plus plus plus more great news. So I would say this IBRX is STRONG BUY BUY BUY

It sickens me how corrupt America is. No MSM coverage ever for ImmunityBio.... Bit if we had it IBRX would be $20-$30 and they would be talking how a BP should buy them. Bla bla bla instead crickets and ImmunityBio is blackballed. The way to look at that is wow BP is really really aware of how ImmunityBio is going to cut their sales to the bone....... :) Can't wait for that and all the ad $$$$ to dry up for MSM

So sick of the daily trading BS

I know and understand the science the company and the huge upside possibilities so I keep holding my 590,000 shares

https://finance.yahoo.com/sectors/healthcare/articles/immunitybio-asco-anktiva-data-reframes-090822028.html